Exact Mass: 487.0616226
Exact Mass Matches: 487.0616226
Found 39 metabolites which its exact mass value is equals to given mass value 487.0616226,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-((4-Chlorophenyl)thio)cyclic-3',5'-GMP
CAY10575
C22H21N3O6S2 (487.08717260000003)
(3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanone phosphate (1:1)
C16H19F5N5O5P (487.10439140000005)
5,7-dichloro-2-trityl-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
ethyl 5-(benzyloxy)-6-broMo-2-(3-ethoxy-3-oxopropyl)-1-Methyl-1H-indole-3-carboxylate
C24H26BrNO5 (487.0994246000001)
2-O-benzyl 1-O-tert-butyl (2S,4R)-4-[(4-bromophenyl)methyl]-5-oxopyrrolidine-1,2-dicarboxylate
C24H26BrNO5 (487.0994246000001)
Fulacimstat
C78274 - Agent Affecting Cardiovascular System D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
cytidine diphosphate choline
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-bromo-3-[4-oxo-4-[4-(2-pyridinyl)-1-piperazinyl]butyl]-2-sulfanylidene-1H-quinazolin-4-one
C21H22BrN5O2S (487.06774920000004)
5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide
C22H21N3O6S2 (487.08717260000003)
2-[[5-cyano-7-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]butanedioic acid
8-((4-Chlorophenyl)thio)cyclic-3,5-GMP
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Benzenesulfonamide, 4-iodo-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-
2-pyridin-4-yl-N-[4-(2-thiazolylsulfamoyl)phenyl]-4-quinolinecarboxamide
C24H17N5O3S2 (487.07727719999997)
2-[[1-[(3-bromophenyl)methyl]-3-indolyl]sulfonyl]-N-(5-methyl-3-isoxazolyl)acetamide
C21H18BrN3O4S (487.02013280000006)
N-[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]-3-(4-nitrophenyl)-3-oxopropanamide
C22H18ClN3O6S (487.06047980000005)
(E)-3-(4-fluorophenyl)-N-[[4-[(3-methoxypyrazin-2-yl)sulfamoyl]phenyl]carbamothioyl]prop-2-enamide
5-Acetyl-2-[2-(6-fluoro-9H-1,3,4,9-tetraaza-fluoren-2-ylsulfanyl)-acetylamino]-4-methyl-thiophene-3-carboxylic acid ethyl ester
CDP-choline(1-)
Conjugate base of CDP-choline(1+) arising from deprotonation of the diphosphate function.
SB 271046 (Hydrochloride)
C20H23Cl2N3O3S2 (487.05578280000003)
SB 271046 Hydrochloride (SB 271046A) is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 9.02, 8.55, and 8.81 for rat, pig and human, respectively. SB 271046 Hydrochloride is over 200 fold selective for the 5-HT6 receptor vs 55 other receptors, binding sites and ion channels. Anticonvulsant activity (EC50=0.16 μM)[1].
(1s,2s,5s,8s)-5-[(4s)-2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
4,4-dichloro-n-{5,5-dichloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-3-methylbutanimidic acid
C18H25Cl4N3O2S (487.04215100000005)
(3s,4s)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)
8-(2-amino-1-hydroxyethyl)-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)
5-[2-(1-hydroxy-4-methoxynaphthalen-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-8,11-dimethyl-4,10-dithia-6,11-diazatricyclo[6.2.1.0²,⁶]undecan-7-one
(3s,4r)-8-[(1r)-2-amino-1-hydroxyethyl]-4-(3-bromo-4-hydroxyphenyl)-3-(3-hydroxyphenoxy)-3,4-dihydro-2h-1-benzopyran-5-ol
C23H22BrNO6 (487.06304120000004)